These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 288082)

  • 1. Morphine and endorphins modulate dopamine turnover in rat median eminence.
    Deyo SN; Swift RM; Miller RJ
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):3006-9. PubMed ID: 288082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methionine-enkephalin on prolactin release and catecholamine levels and turnover in the median eminence.
    Ferland L; Fuxe K; Eneroth P; Gustafsson JA; Skett P
    Eur J Pharmacol; 1977 May; 43(1):89-90. PubMed ID: 16758
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug actions on dopamine turnover in the median eminence.
    Moore KE; Gudelsky GA
    Adv Biochem Psychopharmacol; 1977; 16():227-35. PubMed ID: 883543
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of morphine on the rates of dopamine turnover in the neural and intermediate lobes of the rat pituitary gland.
    Lookingland KJ; Moore KE
    Life Sci; 1985 Sep; 37(13):1225-9. PubMed ID: 2995741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin in CSF selectively increases dopamine turnover in the median eminence.
    Annunziato L; Moore KE
    Life Sci; 1978 Jun; 22(22):2037-41. PubMed ID: 672445
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the effects of haloperidol on dopamine turnover in the striatum, olfactory tubercule and median eminence.
    Gudelsky GA; Moore KE
    J Pharmacol Exp Ther; 1977 Jul; 202(1):149-56. PubMed ID: 874811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of tolerance to the prolactin-releasing action of morphine and its modulation by hypothalamic dopamine.
    Deyo SN; Swift RM; Miller RJ; Fang VS
    Endocrinology; 1980 May; 106(5):1469-74. PubMed ID: 7363859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the site of the haloperidol-induced, prolactin-mediated increase of dopamine turnover in the median eminence: studies in rats with complete hypothalamic deafferentations.
    Gudelsky GA; Annunziato L; Moore KE
    J Neural Transm; 1978; 42(3):181-92. PubMed ID: 690628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum.
    Gudelsky GA; Moore EK
    J Neural Transm; 1976; 38(2):95-105. PubMed ID: 1271052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term ACTH induced diminished responsiveness of prolactin secretion to morphine.
    Kanyicska B; Stark E; Horváth G; Simonyi A; Fekete MI
    Life Sci; 1983 Jul; 33(1):55-63. PubMed ID: 6306374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endogenous opioids in the stress- and estrogen-induced activation of prolactin release.
    Deyo SN; Miller RJ
    Life Sci; 1982 Nov 15-22; 31(20-21):2171-5. PubMed ID: 7162335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lateral and medial median eminence: distribution of dopamine, norepinephrine, and luteinizing hormone-releasing hormone and the effect of prolactin on catecholamine turnover.
    Selmanoff M
    Endocrinology; 1981 May; 108(5):1716-22. PubMed ID: 6111445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased dopamine turnover in the median eminence in response to suckling in the lactating rat.
    Selmanoff M; Wise PM
    Brain Res; 1981 May; 212(1):101-15. PubMed ID: 7225847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suckling decreases dopamine turnover in both medial and lateral aspects of the median eminence in the rat.
    Selmanoff M; Gregerson KA
    Neurosci Lett; 1985 Jun; 57(1):25-30. PubMed ID: 4041019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of estrogen on prolactin and tuberoinfundibular dopaminergic neurons.
    Eikenburg DC; Ravitz AJ; Gudelsky GA; Moore KE
    J Neural Transm; 1977; 40(4):235-44. PubMed ID: 881623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute restraint stress decreases dopamine synthesis and turnover in the median eminence: a model for the study of the inhibitory neuronal influences on tuberoinfundibular dopaminergic neurons.
    Demarest KT; Moore KE; Riegle GD
    Neuroendocrinology; 1985 Nov; 41(5):437-44. PubMed ID: 4058676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia.
    Schmauss C; Emrich HM
    Biol Psychiatry; 1985 Nov; 20(11):1211-31. PubMed ID: 2996642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of opioid drugs on the release of dopamine and 5-hydroxytryptamine from rat striatum following activation of nicotinic-cholinergic receptors.
    Westfall TC; Grant H; Naes L; Meldrum M
    Eur J Pharmacol; 1983 Aug; 92(1-2):35-42. PubMed ID: 6628536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine and naloxone: effects on beta-endorphin immunoreactivity in canine plasma and secretions from rat pituitaries.
    Levin ER; Sharp B; Meyer NV; Carlson HE
    Endocrinology; 1981 Jul; 109(1):146-51. PubMed ID: 6263581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin release and tuberoinfundibular dopaminergic neuronal activity following single and double injections of morphine.
    Callahan P; Grandison L; Rabii J
    Brain Res; 1986 Aug; 381(1):106-12. PubMed ID: 3489504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.